Literature DB >> 10362790

Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma.

K Pulford1, B Falini, J Cordell, A Rosenwald, G Ott, H K Müller-Hermelink, K A MacLennan, L Lamant, A Carbone, E Campo, D Y Mason.   

Abstract

The (2;5) translocation, found in many T-cell and null cell anaplastic large cell lymphomas (ALCLs), creates a hybrid gene encoding the 80-kd NPM-ALK protein. Typically neoplastic cells show labeling of both nucleus and cytoplasm for anaplastic lymphoma kinase (ALK) and for the N-terminus of nucleophosmin (NPM). However, 10-20% of cases exhibit cytoplasmic labeling only for ALK, indicating the probable presence of variants of the classical (2;5) translocation that do not involve the NPM gene. We report the detection (using Western blotting and an in vitro kinase assay) in seven such ALCL cases, of ALK proteins with molecular masses of 85 kd, 97 kd (one case exhibiting a (2;3)(p23;q21) translocation), 104 kd (one case carried a (1;2)(q21;p23) translocation), and 113 kd. Tyrosine kinase activity was detected in four of these proteins, but the N-terminal portion of NPM could not be detected. These results show how ALCL cases that express ALK proteins other than NPM-ALK can be detected by sensitive biochemical techniques using routine cryostat sections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362790      PMCID: PMC1866626          DOI: 10.1016/S0002-9440(10)65421-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  t(1;2)(q21;p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma.

Authors:  A Rosenwald; G Ott; K Pulford; T Katzenberger; J Kühl; J Kalla; M M Ott; D Y Mason; H K Müller-Hermelink
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

2.  A novel variant translocation t(2;13) (p23;q34) in Ki-1 large cell anaplastic lymphoma.

Authors:  L Sainati; A Montaldi; M Stella; M C Putti; L Zanesco; G Basso
Journal:  Br J Haematol       Date:  1990-08       Impact factor: 6.998

3.  Major nucleolar proteins shuttle between nucleus and cytoplasm.

Authors:  R A Borer; C F Lehner; H M Eppenberger; E A Nigg
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

4.  A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences.

Authors:  D Martin-Zanca; S H Hughes; M Barbacid
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

5.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

6.  Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.

Authors:  B Falini; K Pulford; A Pucciarini; A Carbone; C De Wolf-Peeters; J Cordell; M Fizzotti; A Santucci; P G Pelicci; S Pileri; E Campo; G Ott; G Delsol; D Y Mason
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

7.  Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3.

Authors:  M Shiota; J Fujimoto; T Semba; H Satoh; T Yamamoto; S Mori
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

8.  Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3.

Authors:  A P Grigg; R D Gascoyne; G L Phillips; D E Horsman
Journal:  Br J Haematol       Date:  1993-01       Impact factor: 6.998

9.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  11 in total

1.  The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells.

Authors:  B Maes; V Vanhentenrijk; I Wlodarska; J Cools; B Peeters; P Marynen; C de Wolf-Peeters
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.

Authors:  B Lawrence; A Perez-Atayde; M K Hibbard; B P Rubin; P Dal Cin; J L Pinkus; G S Pinkus; S Xiao; E S Yi; C D Fletcher; J A Fletcher
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).

Authors:  G W Colleoni; J A Bridge; B Garicochea; J Liu; D A Filippa; M Ladanyi
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Expression of the ALK tyrosine kinase gene in neuroblastoma.

Authors:  L Lamant; K Pulford; D Bischof; S W Morris; D Y Mason; G Delsol; B Mariamé
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

5.  Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity.

Authors:  Luis Hernández; Sílvia Beà; Beatriz Bellosillo; Magda Pinyol; Brunangelo Falini; Antonino Carbone; German Ott; Andreas Rosenwald; Alberto Fernández; Karen Pulford; David Mason; Stephan W Morris; Eugenio Santos; Elias Campo
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms.

Authors:  Teresa Marafioti; Stefano Ascani; Karen Pulford; Elena Sabattini; Milena Piccioli; Margaret Jones; Pier Luigi Zinzani; Georges Delsol; David Y Mason; Stefano A Pileri
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

7.  EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues.

Authors:  Maria Paola Martelli; Gabriella Sozzi; Luis Hernandez; Valentina Pettirossi; Alba Navarro; Davide Conte; Patrizia Gasparini; Federica Perrone; Piergiorgio Modena; Ugo Pastorino; Antonino Carbone; Alessandra Fabbri; Angelo Sidoni; Shigeo Nakamura; Marcello Gambacorta; Pedro Luis Fernández; Jose Ramirez; John K C Chan; Walter Franco Grigioni; Elias Campo; Stefano A Pileri; Brunangelo Falini
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

Review 8.  Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Authors:  Thomas R Webb; Jake Slavish; Rani E George; A Thomas Look; Liquan Xue; Qin Jiang; Xiaoli Cui; Walter B Rentrop; Stephan W Morris
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

9.  The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissues.

Authors:  Gabriella Sozzi; Maria Paola Martelli; Davide Conte; Piergiorgio Modena; Valentina Pettirossi; Stefano A Pileri; Brunangelo Falini
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

10.  ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.

Authors:  Melissa Pulitzer; Olakunle Ogunrinade; Oscar Lin; Peter Steinherz
Journal:  J Cutan Pathol       Date:  2015-02-05       Impact factor: 1.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.